Nathan D. Jorgensen - 07 Aug 2023 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Financial Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
07 Aug 2023
Net transactions value
-$2,227
Form type
4
Filing time
09 Aug 2023, 16:37:22 UTC
Previous filing
10 May 2023
Next filing
06 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability $2,227 -834 -0.54% $2.67 152,791 07 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").